Dicentric Chromosome (DC) Assay as a Biodosimetery Complementary Tool for Individualized Physical Dosimetry Assessment in Sequential Therapeutic mIBG for High Risk Neuroblastoma. A Feasibility Study

被引:0
|
作者
Balaguer, J. [1 ]
Montoro, A. [2 ]
Sebastia, N. [2 ]
Torres, I. [3 ]
Loaiza, J. L. [4 ]
Olivas, C. [5 ]
Bautista, J. A. [2 ]
Adria, M. [2 ]
Pascual, V. [2 ]
Ibanez, B. [6 ]
Campayo, J. M. [2 ]
Villaescusa, J. I. [2 ]
Bello, P. [4 ]
Canete, A. [1 ]
Castel, V. [1 ]
机构
[1] Hosp La Fe, Paediat Oncol, Valencia, Spain
[2] Hosp La Fe, Radiat Protect Unit, Valencia, Spain
[3] Hosp La Fe, Radiat Phys Sect, Nucl Med Unit, Valencia, Spain
[4] Hosp La Fe, Nucl Med Unit, Valencia, Spain
[5] Hosp La Fe, Radiopharmacol Nucl Med Unit, Valencia, Spain
[6] Hosp La Fe, Nucl Med, Valencia, Spain
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-0483
引用
收藏
页码:S193 / S193
页数:1
相关论文
共 1 条
  • [1] Assessment of the dicentric chromosome assay as a biodosimetry tool for more personalized medicine in a case of a high risk neuroblastoma 131I-mIBG treatment
    Maria Chimeno, Jose
    Sebastia, Natividad
    Torres-Espallardo, Irene
    Balaguer, Julia
    Candela-Juan, Cristian
    Luis Loaiza, Jose
    Adria, Mar
    Ibanez-Rosello, Blanca
    Canete, Adela
    Marti-Bonmati, Luis
    Montoro, Alegria
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2018, 95 (03) : 314 - 320